Skip to main content
ACS Pharmacology & Translational Science logoLink to ACS Pharmacology & Translational Science
. 2026 Feb 2;9(2):461. doi: 10.1021/acsptsci.6c00037

Correction to “Newly Synthesized Indolylacetic Derivatives Reduce Tumor Necrosis Factor-Mediated Neuroinflammation and Prolong Survival in Amyotrophic Lateral Sclerosis Mice”

Angela Corvino, Giuseppe Caliendo, Ferdinando Fiorino, Francesco Frecentese, Valeria Valsecchi, Giovanna Lombardi, Serenella Anzilotti, Giorgia Andreozzi, Antonia Scognamiglio, Rosa Sparaco, Elisa Perissutti, Beatrice Severino, Michele Gargiulo, Vincenzo Santagada, Giuseppe Pignataro
PMCID: PMC12910488  PMID: 41710754

The authors regret that Figures and in the published manuscript contain minor inaccuracies. Specifically, Figure displays an extra data point (six blots instead of the correct five), and in Figure the labels for compound III and compound IV were inadvertently swapped. The correct new Figures are now provided. These errors do not affect the scientific integrity or overall conclusions of the paper, as the main findings remain unchanged. The authors sincerely apologize for any confusion or inconvenience this may have caused.

6.

6

7.

7


Articles from ACS Pharmacology & Translational Science are provided here courtesy of American Chemical Society

RESOURCES